Alexion Pharmaceuticals Stock News

Alexion Pharmaceuticals decided against selling itself, the biotech company said in a news release on Friday — prodding ALXN stock to jump. An activist investor suggested it launch a sale.

Shares of Alexion Pharmaceuticals ALXN, +2.36% are up 6% in morning trading after the company halted its stock in premarket trading to announce that it would not consider a sale, as recommended by Ell

Although PEG is categorized under value investing, it follows the principles of both growth and value investing.

What bargain hunting? Stocks with a rising P/E can also be worth buying too.

ALXN vs. ILMN: Which Stock Is the Better Value Option?

Here are four stocks that boast promising prospects and are most likely to be takeout targets.

Alexion (ALXN) gets Japan Ministry of Health, Labour and Welfare's approval for the label expansion of Soliris.

Alexion (ALXN) reported earnings 30 days ago. What's next for the stock?

We highlight a few principal players from the biotech sector, which are likely to witness a winning run in the near term.

ALXN vs. CBM: Which Stock Is the Better Value Option?

Bet on these top-ranked stocks with rising P/E for outsized gains.

Alexion's (ALXN) stock rises 10% in the year so far as Soliris maintains momentum and Ultomiris gains further traction.

Given the bullishness and record-high market, we have screened for five S&P 500 stocks that are most loved by the brokerage firms.

The short interest data are out for the most recent settlement date, October 31. Generally speaking, companies within the biotech industry are considered a riskier group of stocks, with big potential

These 3 big stock charts, including MCD stock, highlight S&P 500 components set up for big potential moves. The post 3 Big Stock Charts for Tuesday: Verizon, McDonald’s, and Alexion Pharmaceuticals